东方证券股份有限公司关于 海能未来技术集团股份有限公司 2025 年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《北京证券交易所股票上市规则》 等有关法律法规、规范性文件等的规定，东方证券股份有限公司作为海能未来技 术集团股份有限公司的保荐机构，负责海能未来技术集团股份有限公司的持续督 导工作，并出具 2025 年度持续督导跟踪报告。 | 项目 | 工作内容 | | --- | --- | | 1.审阅公司信息披露文件 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 无 | | 2.督导公司建立健全并有效执行规则制度 | | | （1）是否督导公司建立健全规则制度（包括但 | | | 不限于公司治理制度、财务内控制度和信息披 | 是 | | 露制度等） | | | （2）公司是否有效执行相关规则制度 | 是 | | 3.募集资金使用监督 | | | （1）查询公司募集资金专户次数 | 每月一次 | | （2）公司募集资金项目进展是否与信息披露文 | 是 | | 件一致 | | | 4.督导公司规范运作 | | | （1）列席公司股东会次数 ...

东方证券股份有限公司 关于海能未来技术集团股份有限公司 向不特定合格投资者公开发行股票之保荐工作总结报告书 海能未来技术集团股份有限公司（以下简称"海能技术"、"公司"）向不 特定合格投资者公开发行股票于 2022 年 10 月 14 日在北京证券交易所上市。东 方证券股份有限公司（以下简称"东方证券"或"保荐机构"）作为海能技术向 不特定合格投资者公开发行股票并在北京证券交易所上市（以下简称"本次发 行"）的保荐机构，履行持续督导职责的期限至 2025 年 12 月 31 日。 截至 2025 年 12 月 31 日，本次发行持续督导期已届满，根据《证券发行上 市保荐业务管理办法》《北京证券交易所股票上市规则》《北京证券交易所证券 发行上市保荐业务管理细则》等有关规定的要求，东方证券出具本保荐总结报告 书。 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 2、本保荐机构及本人自愿接受中国证监会和北京证券交易所对保荐总结报 告书相关事项进行的任何质询和调查。 3、本保荐机构及本人 ...

Core Viewpoint - The article discusses the recent implementation of refinancing optimization measures in the North Exchange, highlighting the positive market response as companies begin to utilize simplified procedures for private placements [3][4]. Group 1: Company Actions - Two companies listed on the North Exchange, Bicon Technology (920879.BJ) and Haineng Technology (920476.BJ), have announced plans to initiate simplified procedures for private placements, with Bicon seeking shareholder approval for a specific issuance [3]. - Both companies aim to raise funds below 100 million yuan and below 20% of their net assets from the previous year, with Bicon's maximum financing limit estimated at 127 million yuan and Haineng's at 89.8 million yuan [3][4]. Group 2: Financial Performance - Bicon Technology reported a revenue of 407 million yuan in the past year, reflecting a year-on-year growth of 14.32%, and a net profit of 82.31 million yuan, up 6.87% [4]. - Haineng Technology achieved a revenue of 362 million yuan, with a year-on-year increase of 16.63%, and a net profit of 42.13 million yuan, which represents a significant growth of 222.3% [4]. Group 3: Dividend Plans - Both companies have announced dividend plans, with Haineng Technology proposing a cash dividend of 1 yuan per 10 shares, totaling approximately 800,910 yuan, while Bicon Technology plans to distribute 1.5 yuan per 10 shares and convert 2 shares for every 10 held, amounting to a total cash payout of 25.11 million yuan and a share conversion of 33.48 million shares [4]. Group 4: Market Response and Future Measures - The initiation of simplified financing procedures by these companies indicates a positive market response to the refinancing policies, showcasing the effectiveness of the North Exchange's optimization measures [4]. - The China Securities Regulatory Commission (CSRC) has announced further enhancements to the refinancing mechanism, including optimizing the identification standards for strategic investors and improving the simplified procedures for refinancing [5].

证券代码：920476 证券简称：海能技术 公告编号：2026-038 海能未来技术集团股份有限公司 2025 年年度报告说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 海能未来技术集团股份有限公司（以下简称"公司"）于 2026 年 3 月 16 日 在北京证券交易所信息披露平台（www.bse.cn）披露了公司《2025 年年度报告》 （公告编号：2026-006），为方便广大投资者结合公司所处行业的特点及发展状 况，更深入了解公司 2025 年度经营的具体情况，公司拟召开 2025 年年度报告说 明会。 本次说明会将采用网络远程的方式举行，投资者可登陆中证网"中证路演中 心"（https://www.cs.com.cn/roadshow/yjsmh/）参与本次说明会。 三、 参加人员 公司董事、总经理：徐渊先生 公司董事会秘书：宋晓东先生 公司财务负责人：崔国强先生 公司保荐代表人：马婧瑶女士 四、 投资者参加方式 本次说明会采用网络方式召开。 二、 说明会召开的 ...

Investment Rating - The investment rating for Haineng Technology (920476.BJ) is "Buy" (maintained) [1] Core Views - The company reported a revenue of 362 million yuan for 2025, representing a year-on-year growth of 16.63%. The net profit attributable to shareholders was 42.13 million yuan, a significant increase of 222.30% year-on-year. The non-recurring net profit reached 35.59 million yuan, up 821.71% year-on-year [4] - The company is expected to maintain strong growth, with projected net profits for 2026-2028 at 53 million yuan, 64 million yuan, and 81 million yuan respectively, corresponding to EPS of 0.62, 0.75, and 0.95 yuan per share. The current price-to-earnings ratios are 34.0, 28.2, and 22.1 times [4] - The company has launched high-end products and is actively upgrading existing products to enhance competitiveness in both domestic and international markets [5] Financial Summary - For 2025, the company achieved a revenue of 362 million yuan, with a year-on-year growth of 16.63%. The net profit attributable to shareholders was 42.13 million yuan, reflecting a year-on-year increase of 222.30% [4][10] - The company’s revenue is projected to grow to 434 million yuan in 2026, 499 million yuan in 2027, and 606 million yuan in 2028, with corresponding net profits of 53 million yuan, 64 million yuan, and 81 million yuan [9][10] - The gross margin is expected to remain stable around 65%, with net margins improving from 10.7% in 2025 to 12.9% in 2028 [10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 362 million yuan for 2025, representing a year-on-year growth of 16.63%, and a net profit attributable to shareholders of 42.13 million yuan, which is a significant increase of 222.30% year-on-year [4] - The company is expected to maintain strong growth, with projected net profits for 2026-2028 at 53 million yuan, 64 million yuan, and 81 million yuan respectively, corresponding to EPS of 0.62, 0.75, and 0.95 yuan per share [4] - The company is actively engaged in the development of high-end scientific instruments and has made significant advancements in product automation and intelligence [5][6] Financial Summary - Revenue is projected to grow from 362 million yuan in 2025 to 434 million yuan in 2026, 499 million yuan in 2027, and 606 million yuan in 2028, with respective year-on-year growth rates of 19.9%, 14.9%, and 21.4% [9] - The gross margin is expected to remain stable, with estimates of 65.1% in 2026, 64.9% in 2027, and 65.5% in 2028 [10] - The net profit margin is projected to improve from 10.7% in 2025 to 10.6% in 2026, 11.9% in 2027, and 12.9% in 2028 [10] - The company has maintained a strong return on equity (ROE), expected to rise from 8.7% in 2025 to 9.4% in 2026, 11.0% in 2027, and 12.8% in 2028 [10] Product Development and Market Position - The company launched the high-end N70 Fourier Transform Near-Infrared Spectrometer in September 2025, which is applicable in various fields such as pharmaceuticals, chemicals, and food [5] - The company has invested 54.11 million yuan in R&D, accounting for 14.96% of its revenue, and has obtained 15 new invention patents and 11 utility model patents [6] - The company is focusing on domestic high-demand sectors and international high-end markets, enhancing its competitive edge through product innovation and automation [5][6]

Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Insights - The company reported a revenue of 362 million yuan for 2025, representing a year-on-year growth of 16.6%, and a net profit attributable to shareholders of 42 million yuan, which is a significant increase of 222.3% [5][8] - The fourth quarter of 2025 saw a revenue of 135 million yuan, up 6.6% year-on-year, and a net profit of 24 million yuan, reflecting a 35.3% increase [5] - The company is positioned to benefit from the "14th Five-Year Plan," with a clear growth momentum in both domestic and international markets [8] Financial Data Summary - The company’s total revenue projections for 2026 and 2027 are 427 million yuan and 494 million yuan, respectively, with corresponding year-on-year growth rates of 17.9% and 15.7% [7] - The net profit attributable to shareholders is expected to reach 59 million yuan in 2026 and 69 million yuan in 2027, with growth rates of 40.1% and 16.7% [7] - The gross margin for 2025 is reported at 65.0%, with a net margin of 11.6%, indicating stable profitability [8]

证券代码：920476 证券简称：海能技术 公告编号：2026-037 海能未来技术集团股份有限公司董事离任公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、董事离任的基本情况 二、合规性说明及影响 （一）人员变动的合规性说明 上述人员离任未导致公司董事会成员人数低于法定最低人数，未导致董事会中兼 任高级管理人员的董事和由职工代表担任的董事人数超过公司董事总数的二分之一， 未导致董事会或者其专门委员会中独立董事所占的比例不符合相关规则或者公司章 程的规定，未导致独立董事中欠缺会计专业人士。 （二）人员变动对公司的影响 刘文玉先生辞去公司董事职务后，仍继续担任公司控股子公司悟空科学仪器（上 海）有限公司董事兼总经理，将继续全面负责公司色谱质谱产品的运营及管理，不会 对公司的日常经营、生产活动产生不利影响。公司及董事会对刘文玉先生董事任职期 间做出的贡献表示衷心的感谢。 三、备查文件 刘文玉先生的《辞职申请》。 本公司刘文玉先生，因个人原因辞任，自 2026 年 3 月 19 日起不再担任董事。该人 ...

证券代码：920476 证券简称：海能技术 公告编号：2026-035 海能未来技术集团股份有限公司 一、 本次股票解除限售数量总额为 79,240 股，占公司总股本 0.10%，可交易时 间为 2026 年 3 月 23 日。 单位：股 股票解除限售公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 二、本次股票解除限售的明细情况及原因 | 序 | 股东姓 | 是否为控 股股东、 | | 本次解限 | 本次解除 | 本次解 除限售 股数占 | 尚未解除 | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | 名或名 称 | 实际控制 人或其一 | 任职情况 | 售原因 | 限售登记 股票数量 | 公司总 股本比 | 限售的股 票数量 | | | | 致行动人 | | | | 例 | | | 1 | 刘朝 | 否 | 离任监事会主席 | B | 13,000 | 0.02% | 39,000 | | 2 | 薛猛 | 否 | 离任监事 | B ...

证券代码：920476 证券简称：海能技术 公告编号：2026-036 海能未来技术集团股份有限公司 关于投资者关系活动记录表的公告 □分析师会议 □路演活动 √其他 （线上会议） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 □特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 二、 投资者关系活动情况 活动时间：2026 年 3 月 17 日 活动地点：线上调研 参会单位及人员：第一场：华源证券研究所、开源证券、长江证券、民生证 券、中金公司、财信证券、联储证券、五矿证券、信达证券、浙商银行、创金合 信基金、建信基金、深圳市尚诚资产管理有限责任公司、上海滦海投资管理有限 公司、中银理财有限责任公司、长城财富保险资产管理股份有限公司、上海临信 资产管理有限公司、尚正基金管理有限公司、西安江岳基金管理有限公司、上海 睿源私募基金管理有限公司、大湾区发展基金管理有限公司、珠海坚果私募基金 管理中心（有限合伙）、陆家嘴国际信托有限公司、泽铭投资、江苏苏豪投资集 团有 ...